Clinical Trial Update: Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a one-step sentinel lymph node biopsy using radiolabeled methylene blue in breast cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Methylene Blue (radiolabeled) (methylene blue)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-06-20